Wonbiogen Co., Ltd. (KOSDAQ: 307280)
South Korea
· Delayed Price · Currency is KRW
1,238.00
+7.00 (0.57%)
Nov 15, 2024, 9:00 AM KST
Wonbiogen Revenue
Wonbiogen had revenue of 6.86B KRW in the quarter ending September 30, 2024, a decrease of -1.28%. This brings the company's revenue in the last twelve months to 29.30B, up 5.06% year-over-year. In the year 2023, Wonbiogen had annual revenue of 29.61B with 10.72% growth.
Revenue (ttm)
29.30B
Revenue Growth
+5.06%
P/S Ratio
1.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
43.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 29.61B | 2.87B | 10.72% |
Dec 31, 2022 | 26.75B | 9.03B | 50.94% |
Dec 31, 2021 | 17.72B | 5.70B | 47.46% |
Dec 31, 2020 | 12.02B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition